The Journal of Practical Medicine >
Mass spectrometry screening and genetic diagnosis of β-ketothiolase deficiency
Received date: 2024-10-18
Online published: 2025-02-19
Objective To assess the efficacy of tandem mass spectrometry?specific indicators in diagnosing β?ketothiolase deficiency （BKD） and to elucidate the associated gene variations contributing to the corresponding pathogenic phenotype， thereby facilitating rapid and accurate diagnosis of BKD. Methods Data from tandem mass spectrometry （MS/MS） screening of dried blood spots collected from 16，071 children between January 2018 and December 2021， along with results from gas chromatography?mass spectrometry （GC?MS） analysis and high?throughput sequencing of positive cases， were analyzed retrospectively. The study aimed to evaluate the contribution of specific MS/MS indicators in the clinical diagnosis of BKD and to trace the genetic etiology of this disease. Results Among the 16 071 subjects screened by MS/MS， 37 cases （2.30‰） exhibited elevated C5OH levels， 41 cases （2.55‰） showed increased C5∶1 levels， and 2 cases were diagnosed with BKD based on GC?MS analysis. When diagnosing BKD using C5OH as a single indicator， the false positive rate was 0.22%， which is lower than that of C5∶1 （0.24%）. The positive predictive value for C5OH was 5.40%， higher than that of C5∶1 （4.88%）. Among the 16 071 pediatric patients， only 2 cases were diagnosed with BKD due to elevated C5OH combined with increased C5∶1 levels， resulting in a positive predictive value of 100%. Whole exome sequencing of these two BKD patients revealed that both carried acetyl?CoA acetyltransferase 1 （ACAT1） gene double allele missense heterozygous mutations. The four previously unreported mutation sites were c.949G > C （p.Asp317His）， c.1063G > A （p.Ala355Thr）， c.146G > A （p.Arg49Lys）， and c.700G > A （p.Glu234Lys）. These findings provide novel insights into the genetic basis of BKD. Conclusions The MS/MS screening indicator C5OH demonstrates superior diagnostic efficacy compared to C5∶1 in diagnosing BKD， as evidenced by lower false positive rates and higher positive predictive values. When diagnosing BKD， the use of combined indicators significantly enhances the accuracy of biochemical diagnosis compared to single indicators. Exome sequencing revealed that all BKD patients carried previously unreported mutations in the ACAT1.
Jiandang LI , Yuhan CHEN , Lei YAN , Huilin HAN , Yupei ZHANG , Wanqiao. ZHANG . Mass spectrometry screening and genetic diagnosis of β-ketothiolase deficiency[J]. The Journal of Practical Medicine, 2025 , 41(3) : 422 -427 . DOI: 10.3969/j.issn.1006-5725.2025.03.018
| 1 | 白科，周昉，刘成军，等. β-酮硫解酶缺乏致非糖尿病性酮症酸中毒救治1例并文献复习［J］. 中国循证儿科杂志，2017，12（4）：304-307. |
| 2 | 王兴，郝胜菊，谢小冬，等. 1例β酮硫解酶缺乏症患儿的遗传学分析［J］. 兰州大学学报（医学版），2022，48（2）：92-94. |
| 3 | DAUM RS， LAMM PH， MAMER OA， et al. A “new” disorder of isoleucine catabolism［J］. Lancet， 1971，2（7737）：1289-1290. doi:10.1016/s0140-6736(71)90605-2 |
| 4 | SASS J O， FUKAO T， MITCHELL G A. Inborn Errors of Ketone Body Metabolism and Transport： An Update for the Clinic and for Clinical Laboratories［J］. J Inborn Errors Metab Screen， 2018，6：1-7. doi:10.1177/2326409818771101 |
| 5 | THERRELL B L， PADILLA C D， BORRAJO G J C， et al. Current Status of Newborn Bloodspot Screening Worldwide 2024： A Comprehensive Review of Recent Activities［J］. Int J Neonatal Screen， 2024， 10（2）：38. doi:10.3390/ijns10020038 |
| 6 | FUKAO T， SASAI H， AOYAMA Y，et al. Recent advances in understanding beta-ketothiolase （mitochondrial acetoacetyl-CoA thiolase， T2） deficiency［J］. J Hum Genet， 2019， 64（2）：99-111. doi:10.1038/s10038-018-0524-x |
| 7 | 顾学范，韩连书，余永国. 中国新生儿遗传代谢病筛查现状及展望［J］. 罕见病研究，2022，1（1）：13-19. |
| 8 | LIN Y， YANG Z， YANG C， et al. C4OH is a potential newborn screening marker-a multicenter retrospective study of patients with beta-ketothiolase deficiency in China［J］. Orphanet J Rare Dis， 2021， 16（1）：224. doi:10.1186/s13023-021-01859-5 |
| 9 | ZHANG W， YANG Y， PENG W， et al. A 7-Year Report of Spectrum of Inborn Errors of Metabolism on Full-Term and Premature Infants in a Chinese Neonatal Intensive Care Unit［J］. Front Genet， 2020， 10：1302. doi:10.3389/fgene.2019.01302 |
| 10 | 张万巧， 梅亚波， 闫磊， 等. 气相色谱-质谱联用技术对新生儿重症监护病房患儿代谢异常的诊断和监测［J］. 中华新生儿科杂志， 2020， 35（6）：411-414. |
| 11 | 韩连书， 田国力， 王维鹏. 新生儿遗传代谢病筛查指标切值建立方法专家共识［J］. 中国实用儿科杂志， 2019， 34（11）： 881-884. |
| 12 | 封志纯， 张万巧. 遗传代谢病筛查诊断系统的现状及未来发展［J］. 中华围产医学杂志， 2021， 24（2）： 81-84. |
| 13 | RICHARDS S， AZIZ N， BALE S， et al. Standards and guidelines for the interpretation of sequence variants： a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology［J］. Genet Med， 2015， 17（5）： 405-424. doi:10.1038/gim.2015.30 |
| 14 | YUAN L， LV Y， LI H， et al. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis［J］. Nat Cell Biol，2015， 17（9）：1169-1181. doi:10.1038/ncb3218 |
| 15 | FUKAO T， MITCHELL G， SASS JO， et al. Ketone body metabolism and its defects［J］. Inherit Metab Dis， 2014， 37（4）：541–551. doi:10.1007/s10545-014-9704-9 |
| 16 | OZAND PT， RASHED M， GASCON GG， et al.3-Ketothiolase deficiency： a review and four new patients with neurologic symptoms［J］. Brain Dev， 1994， 16 Suppl：38-45. doi:10.1016/0387-7604(94)90095-7 |
| 17 | BUHAS D， BERNARD G， FUKAO T， et al. A treatable new cause of chorea： beta-ketothiolase deficiency［J］.Mov Disord， 2013， 28（8）：1054-1056. doi:10.1002/mds.25538 |
| 18 | 张万巧，闫磊，朱丽娜，等. 中国北方3-羟基异戊酰肉碱异常患儿代谢及遗传分析［J］. 临床儿科杂志，2023，41（10）：692-696. |
| 19 | GRüNERT S C， SASS J O. 2-methylacetoacetyl-coenzyme A thiolase （beta-ketothiolase） deficiency： one disease-two pathways［J］.Orphanet J Rare Dis， 2020， 15（1）：106. doi:10.1186/s13023-020-01357-0 |
/
| 〈 |
|
〉 |